NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£216M
Sector
HEALTH
Published
22 Feb 2022
Delivery
01 Mar 2022 to 01 Mar 2024
Deadline
21 Sep 2021 13:00

Concepts

Location

Geochart for 1 buyers and 31 suppliers

1 buyer

31 suppliers

Description

NHS Framework for the Midlands and East, Branded Medicines - Tranche A and Annual Tranche Offer reference number: CM/PHR/20/5602 CM/PHR/20/5602/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A. Period of framework: 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5602/02 - NHS Framework for the Midlands and East Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Award Detail

1 Allergan (Marlow)
  • Value: £216,078,796
2 Accord (None)
  • Value: £216,078,796
3 Roche Products (Garden City)
  • Value: £216,078,796
4 Sandoz (Camberley)
  • Value: £216,078,796
5 Amgen (Cambridge)
  • Value: £216,078,796
6 Napp Pharmaceuticals (Cambridge)
  • Value: £216,078,796
7 Novo Nordisk (Gatwick)
  • Value: £216,078,796
8 Pfizer (None)
  • Value: £216,078,796
9 Vifor Pharma (London)
  • Value: £216,078,796
10 Ipsen (Slough)
  • Value: £216,078,796
11 Janssen Cilag (High Wycombe)
  • Value: £216,078,796
12 Teva (Castleford)
  • Value: £216,078,796
13 Merck Serono (Feltham)
  • Value: £216,078,796
14 Chugai Pharma (Chiswick)
  • Value: £216,078,796
15 Pharmacosmos (Reading)
  • Value: £216,078,796
16 Merz (Hemel Hempstead)
  • Value: £216,078,796
17 Eli Lilly (Basingstoke)
  • Value: £216,078,796
18 Merck Sharpe & Dohme (London)
  • Value: £216,078,796
19 Zentiva Pharma (London)
  • Value: £216,078,796
20 Thornton & Ross (Huddersfield)
  • Value: £216,078,796
21 Astrazeneca (Luton)
  • Value: £216,078,796
22 Bristol Myers Squibb (Uxbridge)
  • Value: £216,078,796
23 Glaxosmithkline (London)
  • Value: £216,078,796
24 Sobi Swedish Orphan Biovitrum (None)
  • Value: £216,078,796
25 Celltrion Healthcare (Slough)
  • Value: £216,078,796
26 Almirall (Runcorn)
  • Value: £216,078,796
27 Takeda (London)
  • Value: £216,078,796
28 Aventis Pharma (Reading)
  • Value: £216,078,796
29 Gedeon Richter (London)
  • Value: £216,078,796
30 Organon Pharmaceuticals (London)
  • Value: £216,078,796
31 Ucb Pharma (Slough)
  • Value: £216,078,796

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Parties appointed to the framework agreement https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HN1S/6rtwXnOcgj1... 03. Framework Agreement and Terms and Conditions- CM_PHR_20_5602 NHS Framework Agreement - NHS Midlands and East Branded Medicines - Tranche A and Annual https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HN1R/bx_wIcr1BTG... CM_PHR_20_5602_02 NHS Midlands and East Branded Medicines - Tranche A Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HN1M/YNva90Hl8j5... CM_PHR_20_5602_01 NHS Midlands and East Branded Medicines - Tranche A Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000HN1N/SANVxz0dVlE...

Reference

Domains